Neurophage Pharmaceuticals
HomeAbout UsOur ScienceNewsCareersContact Us

Our Science

. . . . . . . . . . . . . . . . . . . . . .

Technology

. . . . . . . . . . . . . . . . . . . . . .

Pipeline

. . . . . . . . . . . . . . . . . . . . . .

IP Overview

. . . . . . . . . . . . . . . . . . . . . .

Resource Links

. . . . . . . . . . . . . . . . . . . . . .

Papers and Posters

. . . . . . . . . . . . . . . . . . . . . .

NeuroPhage’s proprietary phage technology potently clears pathologic protein aggregates, which are hallmarks of Alzheimer's and Parkinson's diseases.